Table 1 Characteristics, anesthetic, and surgical data of patients in the ondansetron and palonosetron groups

Age (years)

44 (41/47)

45 (42/48)

0.334

Weight (kg)

68.4 ± 10.7

70.3 ± 12.0

0.317

Height (cm)

158 ± 6

159 ± 5

0.609

Body mass index (kg/m²)

27.2 ± 3.9

27.7 ± 4.0

0.453

Motion sickness/previous PONV

7.1%

5.7%

0.730

Smoking

0%

1.4%

1.000

Hypertension

22.8%

27.1%

0.558

Diabetes mellitus

4.2%

1.4%

0.620

Other comorbidities

15.7%

8.5%

0.301

Fasting time (minutes)

770 (660/900)

720 (600/900)

0.508

Use of atropine

1.4%

10.0%

0.063

Use of ephedrine

20.0%

25.7%

0.421

Midazolam total dose (mg)

4.87 ± 1.8

4.8 ± 2.0

0.750

Duration of anesthesia (minutes)

95 (80/111)

90 (80/105)

0.242

Time in post-anesthesia care unit (minutes)

60 (55/66)

60 (55/65)

0.779